What is the mechanism of action for orencia in ra?

How orencia stops joint inflammation in rheumatoid arthritis

Orencia blocks a signal that activates T-cells, the immune cells that drive the chronic inflammation in rheumatoid arthritis. By binding to CD80 and CD86 on antigen-presenting cells, it prevents those cells from engaging the CD28 receptor on T-cells. The missing signal stops T-cells from becoming fully active, reducing their release of inflammatory cytokines and slowing joint damage.

How orencia differs from TNF inhibitors like Humira

Orencia targets T-cell activation upstream of TNF production. TNF inhibitors directly block the already-made TNF cytokine. Because orencia works at an earlier step, it may help patients who did not respond to TNF blockers. Clinical trials showed orencia works in TNF-failure cases, but it takes longer to reach full effect than TNF drugs.

When orencia gets used after other treatments fail

Doctors turn to orencia after methotrexate alone fails or after TNF inhibitors stop working. Guidelines list orencia as a non-TNF biologic option for moderate-to-severe rheumatoid arthritis. Its intravenous or subcutaneous routes give patients and doctors a choice based on convenience and insurance coverage.

What happens if orencia gets stopped suddenly

T-cell activation resumes once orencia is removed from the system. Patients who abruply discontinue the drug often see flare-ups of joint swelling and pain within weeks. Gradual tapering under medical supervision helps kontroll the return of inflammation.

How long orencia stays in the body

After intravenous dosing, orencia has a half-life of roughly 13 days. Subcutaneous weekly injections keep blood levels steady. Patients who stop the drug completely see it wash out of the body over 8–10 weeks.